ClearAlpha Technologies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
ClearAlpha Technologies's BMY Position: Q2 2024 in Review
ClearAlpha Technologies sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 9,083 shares — an estimated $493K sold.
ClearAlpha Technologies first reported a position in BMY in Q1 2024 and held it in 1 quarter. The position peaked at $493K in Q1 2024. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.
- ClearAlpha Technologies reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
- ClearAlpha Technologies sold 9,083 Bristol-Myers Squibb shares in Q2 2024, an estimated $493K.
- ClearAlpha Technologies first reported a position in Bristol-Myers Squibb in Q1 2024 and held it in 1 quarter.
- ClearAlpha Technologies's Bristol-Myers Squibb position peaked at $493K in Q1 2024.
- 2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.
Based on ClearAlpha Technologies's 13F filing for Q2 2024, filed 13 Aug 2024.